title: [Nitrofurantoin-induced lupus-like syndrome associated with hepatitis].
authors.forename: V
authors.initials: V
authors.lastname: Salle
authors.forename: B
authors.initials: B
authors.lastname: Lafon
authors.forename: A
authors.initials: A
authors.lastname: Smail
authors.forename: R
authors.initials: R
authors.lastname: Cévallos
authors.forename: D
authors.initials: D
authors.lastname: Chatelain
authors.forename: M
authors.initials: M
authors.lastname: Andréjak
authors.forename: J P
authors.initials: JP
authors.lastname: Ducroix
mesh_terms: D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008099:Liver / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000188:drug therapy; D009582:Nitrofurantoin / Q000008:administration & dosage / Q000009:adverse effects*; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy
chemical_list: D000892:Anti-Infective Agents, Urinary; D000893:Anti-Inflammatory Agents; D009582:Nitrofurantoin; D011241:Prednisone